On September 14, 2020, our Phoenix laboratory began performing a portion of our alternate donor antibody screen on the Ortho Clinical Diagnostics VISION Analyzer. This instrumentation change was necessary as Ortho Clinical Diagnostics will be discontinuing support of the existing ProVue instrumentation in the future.
We will notify you of the transition date of our other four laboratories. To read more about this change, click here: Communications
An exciting enhancement is implementing January 20, 2020 in our Special Testing laboratory as we mov...
CTS received notification from Sanochemia Pharmazeutika AG of their intent to immediately discontinu...
On Wednesday August 15, 2018 at 11:00AM PDT, we will be hosting a webinar regarding the changes to F...
FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screen...
Beginning June 1, 2020 all 5 CTS laboratories will being transitioning from the Grifols Procleix Ult...
As a service to our partners, CTS provides a copy of all licenses and accreditations on our website....